Literature DB >> 8017462

Diabetic dyslipidemia.

D J Betteridge1.   

Abstract

Diabetes is associated with increased morbidity and mortality from cardiovascular disease in the absence of the major risk factors: cigarette smoking, hypertension, and serum cholesterol concentration. When these risk factors are present, the attributable risk to each factor alone and to the combination of risk factors is higher in diabetics than in nondiabetics. Thus, stringent measures to correct risk factors for cardiovascular disease have been advocated in diabetic patients. In addition to hypercholesterolemia, other lipid and lipoprotein abnormalities collectively referred to as diabetic dyslipidemia are likely to contribute to vascular risk. Hypertriglyceridemia often associated with low high-density lipoprotein cholesterol is common in non-insulin-dependent diabetes mellitus patients and is associated with insulin resistance. Recent information in diabetic patients pointing to the association of hypertriglyceridemia with accumulation of remnant particles and alterations in low-density lipoprotein subfractions helps to explain the strong relationship between hypertriglyceridemia and vascular risk in these individuals. Although there are as yet no intervention trials with lipid-lowering diets or drugs in diabetic patients to judge the impact on vascular disease, national and international bodies have furnished guidelines for the identification and treatment of lipid disorders in diabetes in the hope of reducing the huge toll of vascular disease in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 8017462     DOI: 10.1016/0002-9343(94)90228-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

Review 1.  Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.

Authors:  B Andersson
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

2.  The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats.

Authors:  N H Ugochukwu; N E Babady; M Cobourne; S R Gasset
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

3.  Vitamin C improves basal metabolic rate and lipid profile in alloxan-induced diabetes mellitus in rats.

Authors:  D U Owu; A B Antai; K H Udofia; A O Obembe; K O Obasi; M U Eteng
Journal:  J Biosci       Date:  2006-12       Impact factor: 1.826

4.  Treatment of lipid disorders in patients with diabetes.

Authors:  Helen M Colhoun; David John Betteridge
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-02

Review 5.  Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?

Authors:  Uyen T Truong; David M Maahs; Stephen R Daniels
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

Review 6.  Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Authors:  Ozlem Soran
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

Review 7.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.

Authors:  Gladys Castaño; Lilia Fernández; Rosa Mas; José Illnait; Meylin Mesa; J C Fernández
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

9.  Evaluation of anti-diabetic potential of leaves and stem of Flacourtia jangomas in streptozotocin-induced diabetic rats.

Authors:  Ajay Kumar Singh; Jyoti Singh
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

10.  Hyperlipidemia and obesity among diabetics at jubail miiltary hospital.

Authors:  K S Al-Ghamdi; R Rehman
Journal:  J Family Community Med       Date:  1998-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.